|
Size: 6452
Comment:
|
Size: 10039
Comment:
|
| Deletions are marked like this. | Additions are marked like this. |
| Line 3: | Line 3: |
| ||||<style="background-color: #E0E0FF; font-weight: bold; text-align: center;">Funding Agency||<style="background-color: #E0E0FF; font-weight: bold; text-align: center;">Title||<style="background-color: #E0E0FF; font-weight: bold; text-align: center;">Period|| ||<style="text-align:center;">{{attachment:CIHR.jpg}}||[[ http://www.cihr-irsc.gc.ca/|Canadian Institutes of Health Research]] || A computational and experimental approach to map and evolutionary analyze protein interactions mediated by peptide recognition domains (Operating Grant MOP-84324)||2007-2015|| ||<style="text-align:center;">{{attachment:CIHR.jpg}}||[[ http://www.cihr-irsc.gc.ca/|Canadian Institutes of Health Research]] ||From correlation to causation in genomics: identifying mechanisms underlying disease (Foundation Grant)<<BR>><<BR>>Pls: Gary Bader, Philip Kim, Jason Moffat, Quaid Morris, Frederick Roth, Jacques Simard.||2015-2022|| |
||||<style="background-color: #E0E0FF; font-weight: bold; text-align: center;">Funding Agency||<style="background-color: #E0E0FF; font-weight: bold; text-align: center;">Title||<style="background-color: #E0E0FF; font-weight: bold; text-align: center;">Grant Period|| ||<style="text-align:center;">{{attachment:UofManitoba.png||width=150}}||[[ http://umanitoba.ca/ |University of Manitoba]]||Integrated multi-omic delineation of SARS-CoV-2-dysregulated cellular processes <<BR>><<BR>>Pl: Kevin Coombs||2020-2021|| ||<style="text-align:center;">{{attachment:nrc.png||width=150}}||[[ https://nrc.canada.ca/en |National Research Council Canada]]||AI for Precision Discovery on Associations in Biological Systems <<BR>><<BR>>Spon Ref: AI4D-109-1<<BR>><<BR>>Pl: Xiaojian Shao, Youlian Pan ||2020-2021|| ||<style="text-align:center;">{{attachment:CZI.png||width=150}}||[[ https://chanzuckerberg.com/ |Chan Zuckerberg Initiative]]||A reference cell atlas of human liver diversity of a lifespan <<BR>><<BR>> Spon Ref: 235319<<BR>><<BR>> PI: Alan Mullen ||2019-2021|| ||<style="text-align:center;">{{attachment:cfref.png||width=150}}||[[ https://www.cfref-apogee.gc.ca/home-accueil-eng.aspx |Canada First Research Excellence Fund]]||Stem cell based approaches to endogenous repair of brain and skeletal muscle <<BR>><<BR>> MBDC2-2019-02 <<BR>><<BR>>PI's: Freda Miller, Alison McGuigan, Peter Zandstra, Penny Gilbert, Sidhartha Goyal, Cindi Morshead, Yun Li, David Kaplan ||2019-2020|| ||<style="text-align:center;">{{attachment:cfref.png||width=150}}||[[ https://www.cfref-apogee.gc.ca/home-accueil-eng.aspx |Canada First Research Excellence Fund]]||Investigating how age-related clonal hematopoiesis drives HSC stemness properties ane how this leads to inflammatory disease of the heart <<BR>><<BR>>Pl: John Dick||2019-2020|| ||<style="text-align:center;">{{attachment:cfref.png||width=150}}||[[ https://www.cfref-apogee.gc.ca/home-accueil-eng.aspx |Canada First Research Excellence Fund]]||Development of novel cell and tissue therapies to treat liver failure <<BR>><<BR>>Pl: Gordon Keller||2019-2020|| ||<style="text-align:center;">{{attachment:OICR.jpeg||width=150}}||[[ https://oicr.on.ca/ |Ontario Institute for Cancer Research]]||Cellular and Genetic Heterogeneity as a Therapeutic Hurdle and Opportunity for Ontarians with Brain Cancer (Operating Grant) <<BR>><<BR>>Pl: Peter Dirks||2017-2021|| ||<style="text-align:center;">{{attachment:OICR.jpeg||width=150}}||[[ https://oicr.on.ca/ |Ontario Institute for Cancer Research]]||Acute Leukemia Translational Initiative (Operating Grant) <<BR>><<BR>>Pl: John Dick||2017-2021|| ||<style="text-align:center;">{{attachment:OICR.jpeg||width=150}}||[[ https://oicr.on.ca/ |Ontario Institute for Cancer Research]]||The Cancer Genome Collaboratory <<BR>><<BR>>Pl: Lincoln Stein <<BR>><<BR>>The authors wish to acknowledge the funding support of the Canada Foundation for Innovation Cyberinfrastructure Initiative, the Ontario Research Fund, BC Knowledge Development Fund and the Ministère de l'Économie, de la Science et l'Innovation for 'The Cancer Genome Collaboratory' project||2016-2022|| ||<style="text-align: center;">{{attachment:NSERC.png||width=200}}||[[http://www.nserc-crsng.gc.ca/|Natural Sciences and Engineering Research Council of Canada]]|| Cell and tissue communication networks<<BR>><<BR>>Pl: Gary Bader||2016-2021|| ||<style="text-align: center;">{{attachment:cfref.png||width=150}}||[[http://www.cfref-apogee.gc.ca/home-accueil-eng.aspx/| Canada First Research Excellence Fund]]||Overcoming Blindness: Differentiation, Purification and Transplantation of Photoreceptors (Operational sub-grant). <<BR>><<BR>> PI: Molly Shoichet.<<BR>><<BR>>Funder acknowledgement statement: "This research was undertaken thanks in part to funding provided to the University of Toronto Medicine by Design initiative, by the Canada First Research Excellence Fund.”||2016-2019|| ||<style="text-align: center;">{{attachment:cfref.png||width=150}}||[[http://www.cfref-apogee.gc.ca/home-accueil-eng.aspx/| Canada First Research Excellence Fund]]||Regulatory network control of neural stem cells for endogenous repair (Operating Grant: C1TPA-2016-01). <<BR>><<BR>> PIs: Gary Bader, Freda Miller, David Kaplan, Derek van der Kooy, Michael Moran, Aaron Wheeler, Cindi Morshead, Quaid Morris, Michael Hoffman, Lincoln Stein, Sidhartha Goyal, Trevor Pugh, Michael Wilson.<<BR>><<BR>>Funder acknowledgement statement: "This research was undertaken thanks in part to funding provided to the University of Toronto Medicine by Design initiative, by the Canada First Research Excellence Fund.”||2016-2019|| ||<style="text-align: center;">{{attachment:cfref.png||width=150}}||[[http://www.cfref-apogee.gc.ca/home-accueil-eng.aspx/| Canada First Research Excellence Fund]]||Pathways to enhance the clinical utility of hematopoietic stem cell transplantation (Operating Grant: C1TPA-2016-02). <<BR>><<BR>> PIs: John Dick, Norman Iscove, Mathieu Lupien, Gary Bader, Quaid Morris, Igor Jurisica, Shana Kelley.<<BR>><<BR>>Funder acknowledgement statement: "This research was undertaken thanks in part to funding provided to the University of Toronto Medicine by Design initiative, by the Canada First Research Excellence Fund.”|| 2016-2019|| ||<style="text-align:center;">{{attachment:CIHR.jpg}}||[[ http://www.cihr-irsc.gc.ca/|Canadian Institutes of Health Research]] ||From correlation to causation in genomics: identifying mechanisms underlying disease (Foundation Grant)<<BR>><<BR>>Pl: Gary Bader||2015-2022|| ||<style="text-align:center;">{{attachment:NewTerryFox.jpg||width=250}}||[[http://www.tfri.ca/|The Terry Fox Research Institute]]|| Development of Stemness-based Prognostic Biomarkers and Therapeutic Targets(Operating Grant: 1047) <<BR>><<BR>>Pl: John Dick||2015-2020|| ||<style="text-align: center;">{{attachment:nih.gif}}||[[http://www.nih.gov/|U.S. NIH]]|| [[http://interactome.baderlab.org/|A human binary interactome reference map by 2020]] (Operational sub-grant:U41-HG001715-18). <<BR>><<BR>> PIs: Marc Vidal, Michael Calderwood, David Hill, Frederick Roth. ||2015-2018|| ||<style="text-align: center;">{{attachment:SU2C.jpg||width=200}}||[[http://www.cancerstemcellteam.com/|Stand Up To Cancer]]||Targeting brain tumour stem cell epigenetic and molecular networks (Operating Sub-Grant: SU2C-AACR-DT-19-15) <<BR>><<BR>>Pls: Peter Dirks, Samuel Weiss, Michael Taylor, Nada Jabado, Cheryl Arrowsmith, Michael Salter, Marco Marra, Mathieu Lupien, Amy Caudy, Trevor Pugh, Gary Bader, Michael Tyers, Wendy Durigon, Warren Mason, Eric Bouffet.||2015-2019|| |
| Line 7: | Line 22: |
| ||<style="text-align: center;">{{attachment:NSERC.png||width=200}}||[[http://www.nserc-crsng.gc.ca/|Natural Sciences and Engineering Research Council of Canada]]|| Cell and tissue communication networks||2016-2021|| ||<style="text-align:center;">{{attachment:OICR.jpeg||width=150}}||[[ https://oicr.on.ca/oicr-programs-and-platforms/innovation-programs/cancer-stem-cell |Ontario Institute for Cancer Research]]||Cancer stem cell program (Operating Grant) <<BR>><<BR>>Pls: John Dick and Gary Bader||2013-2017|| ||<style="text-align: center;">{{attachment:SU2C.jpg||width=200}}||[[http://www.standup2cancer.ca/en/dream_teams/view/cancer_stem_cell_dream_team/|Stand Up To Cancer]]||Targeting brain tumour stem cell epigenetic and molecular networks (Operating Sub-Grant: SU2C-AACR-DT-19-15) <<BR>><<BR>>Pls: Peter Dirks, Samuel Weiss, Michael Taylor, Nada Jabado, Cheryl Arrowsmith, Michael Salter, Marco Marra, Mathieu Lupien, Amy Caudy, Trevor Pugh, Gary Bader, Michael Tyers, Wendy Durigon, Warren Mason, Eric Bouffet.||2015-2017|| ||<style="text-align:center;">{{attachment:Gen.jpg||width=220}}||[[https://www.genomecanada.ca/|Genome Canada]]|| Activity 1: Identification and validation of the effect of common and low frequency genetic variants on breast cancer (Operating Sub-Grant) <<BR>><<BR>>Pls: Jacques Simard and Gary Bader.||2013-2017|| ||<style="text-align:center;">{{attachment:Gen.jpg||width=220}}||[[https://www.genomecanada.ca/|Genome Canada]]|| Activity 2: Identification and validation of the rare variants /mutations in novel breast cancer susceptibility (Operating Sub-Grant) <<BR>><<BR>>Pls: Jacques Simard and Gary Bader.||2013-2017|| ||<style="text-align:center;">{{attachment:TerryFox.jpg||width=250}}||[[http://www.tfri.ca/|The Terry Fox Research Institute]]|| Development of Stemness-based Prognostic Biomarkers and Therapeutic Targets(Operating Grant: 1047) <<BR>><<BR>>Pls: John Dick, Gary Bader.||2015-2020|| ||<style="text-align: center;">{{attachment:nih.gif}}||[[http://www.nih.gov/|U.S. NIH]] via [[http://genome.gov/|National Human Genome Research Institute (NHGRI)]]||Pathway Commons Research resource for biological pathways <<BR>><<BR>>[[http://www.pathwaycommons.org/|Pathway Commons]] is a collaboration between the Bader Lab at the University of Toronto, the Sander Lab at the cBio Center for Information Biology, Dana-Farber Cancer Institute and the Computational biology collaboratory at Harvard Medical School, and the Demir Lab, Oregon Health & Science University.||2008-2018|| |
||<style="text-align:center;">{{attachment:OICR.jpeg||width=150}}||[[ https://oicr.on.ca/oicr-programs-and-platforms/innovation-programs/cancer-stem-cell |Ontario Institute for Cancer Research]]||Cancer stem cell program (Operating Grant) <<BR>><<BR>>Pl: John Dick||2013-2017|| ||<style="text-align:center;">{{attachment:Gen.jpg||width=220}}||[[https://www.genomecanada.ca/|Genome Canada]]|| Personalised Risk Stratification for Prevention and Early Detection of Breast Cancer (Operating Sub-Grant) <<BR>><<BR>>Pls: Bartha Maria Knoppers, and Jacques Simard.||2013-2017|| ||<style="text-align: center;">{{attachment:nih.gif}}||[[http://www.nih.gov/|U.S. NIH]] via [[http://www.ncrr.nih.gov/|National Center for Research Resources (NCRR)]]||[[http://nrnb.org/|National Resource for Network Biology (NRNB)]], PIs: Trey Ideker, Chris Sander, Alex Pico, Gary Bader.<<BR>><<BR>>This work was supported by NRNB (U.S. National Institutes of Health, National Center for Research Resources grant number P41 GM103504)||2012-2017|| ||<style="text-align: center;">{{attachment:nih.gif}}||[[http://www.nih.gov/|U.S. NIH]] via [[http://www.nigms.nih.gov/|National Institute of General Medical Sciences (NIGMS)]]||[[http://www.cytoscape.org/|Cytoscape: A Modeling Platform for Biomolecular Networks]]<<BR>><<BR>>Funding for continued development and maintenance of Cytoscape is provided by the U.S. National Human Genome Research Institute (NHGRI) under award number HG009979.<<BR>><<BR>>Cytoscape user support, education and new initiatives are supported by the National Resource for Network Biology (NRNB) under award numbers P41 RR031228 and GM103504.<<BR>><<BR>>PIs: Trey Ideker, Gary Bader.||2009-2017|| ||<style="text-align: center;">{{attachment:nih.gif}}||[[http://www.nih.gov/|U.S. NIH]] via [[http://genome.gov/|National Human Genome Research Institute (NHGRI)]]||Pathway Commons Research resource for biological pathways. <<BR>><<BR>>[[http://www.pathwaycommons.org/|Pathway Commons]] is a collaboration between the Bader Lab at the University of Toronto, the Sander Lab at the cBio Center for Information Biology, Dana-Farber Cancer Institute and the Computational biology collaboratory at Harvard Medical School, and the Demir Lab, Oregon Health & Science University (Grant: U41 HG006623).||2008-2018|| ||<style="text-align:center;">{{attachment:CIHR.jpg}}||[[ http://www.cihr-irsc.gc.ca/|Canadian Institutes of Health Research]] || A computational and experimental approach to map and evolutionary analyze protein interactions mediated by peptide recognition domains (Operating Grant MOP-84324)<<BR>><<BR>>Pl: Gary Bader||2007-2017|| |
| Line 15: | Line 29: |
| ||<style="text-align: center;">{{attachment:nih.gif}}||[[http://www.nih.gov/|U.S. NIH]] via [[http://www.ncrr.nih.gov/|National Center for Research Resources (NCRR)]]||Resource for Analysis, Vizualization, and Integration of Networks (RAVIN), PIs: Trey Ideker, Chris Sander, James Fowler, Bruce Conklin, Gary Bader, Benno Schwikowski.<<BR>><<BR>>This work was supported by NRNB (U.S. National Institutes of Health, National Center for Research Resources grant number P41 GM103504)||2010-2017|| ||<style="text-align: center;">{{attachment:nih.gif}}||[[http://www.nih.gov/|U.S. NIH]]|| [[http://interactome.baderlab.org/|A human binary interactome reference map by 2020]] (Operational sub-grant:U41-HG001715-18). <<BR>><<BR>> PIs: Marc Vidal, Michael Calderwood, David Hill, Frederick Roth. ||2015-2018|| ||<style="text-align: center;">{{attachment:nih.gif}}||[[http://www.nih.gov/|U.S. NIH]] via [[http://www.nigms.nih.gov/|National Institute of General Medical Sciences (NIGMS)]]||[[http://www.cytoscape.org/|Cytoscape: A Modeling Platform for Biomolecular Networks]]<<BR>><<BR>>Funding for continued development and maintenance of Cytoscape is provided by the U.S. National Institute of General Medical Sciences (NIGMS) under award number GM070743. <<BR>><<BR>>PIs: Trey Ideker, Gary Bader, Alex Pico, Benno Schwikowski.||2009-2016|| ||<style="text-align: center;">{{attachment:CFREF.jpg}}||[[http://www.cfref-apogee.gc.ca/home-accueil-eng.aspx/| Canada First Research Excellence Fund]]||Regulatory network control of neural stem cells for endogenous repair (Operating Grant: C1TPA-2016-01). <<BR>><<BR>> PIs: Gary Bader, Freda Miller, David Kaplan, Derek van der Kooy, Michael Moran, Aaron Wheeler, Cindi Morshead, Quaid Morris, Michael Hoffman, Lincoln Stein, Sidhartha Goyal, Trevor Pugh, Michael Wilson.||2016-2019|| ||<style="text-align: center;">{{attachment:CFREF.jpg}}||[[http://www.cfref-apogee.gc.ca/home-accueil-eng.aspx/| Canada First Research Excellence Fund]]||Pathways to enhance the clinical utility of hematopoietic stem cell transplantation (Operating Grant: C1TPA-2016-02). <<BR>><<BR>> PIs: John Dick, Norman Iscove, Mathieu Lupien, Gary Bader, Quaid Morris, Igor Jurisica, Shana Kelley.|| 2016-2019|| |
Funding Agency |
Title |
Grant Period |
|
|
Integrated multi-omic delineation of SARS-CoV-2-dysregulated cellular processes |
2020-2021 |
|
|
AI for Precision Discovery on Associations in Biological Systems |
2020-2021 |
|
|
A reference cell atlas of human liver diversity of a lifespan |
2019-2021 |
|
|
Stem cell based approaches to endogenous repair of brain and skeletal muscle |
2019-2020 |
|
|
Investigating how age-related clonal hematopoiesis drives HSC stemness properties ane how this leads to inflammatory disease of the heart |
2019-2020 |
|
|
Development of novel cell and tissue therapies to treat liver failure |
2019-2020 |
|
|
Cellular and Genetic Heterogeneity as a Therapeutic Hurdle and Opportunity for Ontarians with Brain Cancer (Operating Grant) |
2017-2021 |
|
|
Acute Leukemia Translational Initiative (Operating Grant) |
2017-2021 |
|
|
The Cancer Genome Collaboratory |
2016-2022 |
|
|
Cell and tissue communication networks |
2016-2021 |
|
|
Overcoming Blindness: Differentiation, Purification and Transplantation of Photoreceptors (Operational sub-grant). |
2016-2019 |
|
|
Regulatory network control of neural stem cells for endogenous repair (Operating Grant: C1TPA-2016-01). |
2016-2019 |
|
|
Pathways to enhance the clinical utility of hematopoietic stem cell transplantation (Operating Grant: C1TPA-2016-02). |
2016-2019 |
|
|
From correlation to causation in genomics: identifying mechanisms underlying disease (Foundation Grant) |
2015-2022 |
|
|
Development of Stemness-based Prognostic Biomarkers and Therapeutic Targets(Operating Grant: 1047) |
2015-2020 |
|
|
A human binary interactome reference map by 2020 (Operational sub-grant:U41-HG001715-18). |
2015-2018 |
|
|
Targeting brain tumour stem cell epigenetic and molecular networks (Operating Sub-Grant: SU2C-AACR-DT-19-15) |
2015-2019 |
|
|
The Cancer Genome Collaboratory (Operating Grant: Discovery Frontiers) |
2014-2018 |
|
|
Cancer stem cell program (Operating Grant) |
2013-2017 |
|
|
Personalised Risk Stratification for Prevention and Early Detection of Breast Cancer (Operating Sub-Grant) |
2013-2017 |
|
|
National Resource for Network Biology (NRNB), PIs: Trey Ideker, Chris Sander, Alex Pico, Gary Bader. |
2012-2017 |
|
|
U.S. NIH via National Institute of General Medical Sciences (NIGMS) |
Cytoscape: A Modeling Platform for Biomolecular Networks |
2009-2017 |
|
U.S. NIH via National Human Genome Research Institute (NHGRI) |
Pathway Commons Research resource for biological pathways. |
2008-2018 |
|
A computational and experimental approach to map and evolutionary analyze protein interactions mediated by peptide recognition domains (Operating Grant MOP-84324) |
2007-2017 |
|
|
Knowledge-based Gene Expression Analysis for Biomedical and Cancer Research (Operating Sub-Grant: 69119295) |
2006-2017 |
|
